skip to main content

Our News

Six widely used drugs now priced at 18% of brand

Effective April 1, 2013, the prices of six widely-used generic drugs dropped to 18 percent of their brand name equivalents – a move that the Council of the Federation expects could save provincial and territorial drug plans up to $100 million.

The Council was created by participating premiers to improve inter-provincial and territorial collaboration on federal issues, including a more coordinated approach to pharmaceutical cost management.

The six drugs represent approximately 20 percent of publicly funded spending on generic drugs in this country. Prior to leveraging their purchasing power to obtain lower generic drug pricing, individual provinces and territories were paying between 25 and 40 percent of brand name prices.

Now Priced at 18% of Brand

Atorvastatin – used to treat high cholesterol
Ramipril – used to treat blood pressure and other cardiovascular conditions
Venlafaxine – used to treat depression and other mental health conditions
Amlodipine – used to treat high blood pressure and angina
Omeprazole – used to treat a variety of gastrointestinal conditions
Rabeprazole – used to treat a variety of gastrointestinal conditions

Sources: Council of the Federation and BC PharmaCare newsletter ed. 13-002

Blue Shield

Blue Shield is a registered trade-mark of Blue Cross Blue Shield Association